Specificity of antinuclear and antiphospholipid antibodies in sera of patients with autoimmune lymphoproliferative disease (ALD)

Keyphrases

• Autoimmune 100%
• Lymphoproliferative Disorders 100%
• Antiphospholipid Antibodies 100%
• Antinuclear Antibodies 100%
• Annexin V 40%
• Fas-mediated Apoptosis 40%
• Antiphospholipid 40%
• Plasma Membrane 20%
• Western Blot 20%
• Immunostaining 20%
• Gene mutation 20%
• Antiphospholipid Syndrome 20%
• Autoantibodies 20%
• Immune Response 20%
• Apoptotic Pathway 20%
• Coagulation 20%
• Heterogeneous Response 20%
• Pediatric Patients 20%
• Anti-DNA Antibodies 20%
• Fine Specificity 20%
• Apoptotic Process 20%
• Thin Layer Chromatography 20%
• FAS Gene 20%
• Antibody Targeting 20%
• β2-glycoprotein I (β2GPI) 20%
• Autoimmune Phenomena 20%
• Nuclear Antigens 20%
• Prothrombin 20%
• Extractable nuclear Antigen 20%
• Cytoplasmic Membrane 20%
• Negatively Charged Phospholipids 20%
• Antithrombin 20%
• S Antibody 20%

Neuroscience

• Phospholipid Antibody 100%
• Antinuclear Antibody 100%
• Lipocortin 5 66%
• Prothrombin 66%
• Cell Nucleus Antigen 66%
• Programmed Cell Death 66%
• Glycoprotein 33%
• Cell Membrane 33%
• Western Blot 33%
• Immunohistochemistry 33%
• Phospholipid 33%
• Gene Mutation 33%
• ELISA 33%
• Antiphospholipid Syndrome 33%
• Autoantibodies 33%
• Protein S 33%

Immunology and Microbiology

• Antinuclear Antibody 100%
• Antiphospholipid Antibody 100%
• Cell Nucleus Antigen 40%
• Programmed Cell Death 40%
• Cell Membrane 20%
• Western Blot 20%
• Immunostaining 20%
• Antiphospholipid Syndrome 20%
• Autoantibodies 20%
• Immune Response 20%
• Glycoprotein 20%
• ELISA 20%
• Gene Mutation 20%
• Thin-Layer Chromatography 20%